Citigroup Cuts GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $84.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price target lowered by Citigroup from $88.00 to $84.00 in a research report released on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other research analysts have also recently weighed in on the company. Piper Sandler upped their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. BTIG Research upped their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Finally, Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Trading Up 0.6%

GEHC opened at $70.77 on Wednesday. The stock has a market capitalization of $32.25 billion, a P/E ratio of 15.52, a P/E/G ratio of 1.55 and a beta of 1.03. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $89.77. The firm’s fifty day simple moving average is $80.78 and its 200 day simple moving average is $78.48. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period in the prior year, the business earned $1.45 EPS. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Allianz SE grew its stake in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. raised its position in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new stake in GE HealthCare Technologies in the third quarter valued at $26,000. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at $26,000. Finally, Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $27,000. 82.06% of the stock is owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.